MeVPMe4 (L), n=2 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: Glu

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - - - - 20.0 37.0 2.0 - - 59
1 - - - - - 195.0 279.5 7.5 - - 482
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 2.5
1 28.5
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 99
1 618

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 118

Number of pre synapses: 964

Number of output connections: 3209

Coverage factor: 1.3

Columnar completeness: 0.21

Area completeness: 0.43

Cell size (columns): 124

Lobula

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVPMe4 (L) % % cumu.
0 Cm8 (R) GABA 34 17.0 27.4% 27.4%
1 Mi10 (R) ACh 8 4.0 6.5% 33.9%
2 MeTu1 (R) ACh 7 3.5 5.6% 39.5%
3 Cm12 (R) GABA 6 3.0 4.8% 44.4%
4 MeTu4f (R) ACh 3 1.5 2.4% 46.8%
5 MeVP14 (R) ACh 3 1.5 2.4% 49.2%
6 MeVP8 (R) ACh 3 1.5 2.4% 51.6%
7 MeVPMe11 (L) Glu 3 1.5 2.4% 54.0%
8 Mi15 (R) ACh 3 1.5 2.4% 56.5%
9 aMe20 (R) unclear 2 1.0 1.6% 58.1%
10 Cm10 (R) GABA 2 1.0 1.6% 59.7%
11 Cm25 (R) Glu 2 1.0 1.6% 61.3%
12 Cm4 (R) Glu 2 1.0 1.6% 62.9%
13 Cm5 (R) GABA 2 1.0 1.6% 64.5%
14 Li20 (R) Glu 2 1.0 1.6% 66.1%
15 MeTu4c (R) ACh 2 1.0 1.6% 67.7%
16 MeVC5 (L) ACh 2 1.0 1.6% 69.4%
17 MeVP29 (R) ACh 2 1.0 1.6% 71.0%
18 MeVP5 (R) unclear 2 1.0 1.6% 72.6%
19 MeVP9 (R) ACh 2 1.0 1.6% 74.2%
20 MeVPMe3 (L) Glu 2 1.0 1.6% 75.8%
21 MeVPMe4 (L) Glu 2 1.0 1.6% 77.4%
22 OA-AL2i4 (R) OA 2 1.0 1.6% 79.0%

Outputs

  instance NT total connections connections /#MeVPMe4 (L) % % cumu.
0 MeTu1 (R) ACh 497 248.5 13.7% 13.7%
1 aMe25 (R) unclear 289 144.5 8.0% 21.6%
2 Cm12 (R) GABA 276 138.0 7.6% 29.2%
3 Cm5 (R) GABA 252 126.0 6.9% 36.2%
4 Cm24 (R) Glu 170 85.0 4.7% 40.8%
5 MeTu4d (R) ACh 154 77.0 4.2% 45.1%
6 MeVP7 (R) ACh 120 60.0 3.3% 48.4%
7 Tm34 (R) Glu 112 56.0 3.1% 51.5%
8 Tm37 (R) Glu 112 56.0 3.1% 54.5%
9 MeVP29 (R) ACh 108 54.0 3.0% 57.5%
10 Cm8 (R) GABA 98 49.0 2.7% 60.2%
11 aMe30 (R) Glu 97 48.5 2.7% 62.9%
12 MeVP57 (R) unclear 88 44.0 2.4% 65.3%
13 TmY10 (R) ACh 88 44.0 2.4% 67.7%
14 Cm3 (R) GABA 83 41.5 2.3% 70.0%
15 Cm14 (R) GABA 76 38.0 2.1% 72.1%
16 Cm13 (R) Glu 68 34.0 1.9% 74.0%
17 MeVP8 (R) ACh 64 32.0 1.8% 75.7%
18 MeVP59 (R) ACh 57 28.5 1.6% 77.3%
19 Cm20 (R) GABA 56 28.0 1.5% 78.8%
20 MeVPMe2 (R) Glu 42 21.0 1.2% 80.0%
21 MeVC23 (R) Glu 35 17.5 1.0% 81.0%
22 TmY9b (R) ACh 35 17.5 1.0% 81.9%
23 SLP250 (R) unclear 34 17.0 0.9% 82.9%
24 aMe20 (R) unclear 29 14.5 0.8% 83.7%
25 MeVP35 (R) unclear 29 14.5 0.8% 84.5%
26 MeTu3c (R) ACh 27 13.5 0.7% 85.2%
27 MeVP9 (R) ACh 27 13.5 0.7% 85.9%
28 LT58 (R) Glu 26 13.0 0.7% 86.7%
29 MeLo7 (R) ACh 22 11.0 0.6% 87.3%
30 MeVPaMe1 (R) ACh 21 10.5 0.6% 87.8%
31 Lat2 (R) unclear 20 10.0 0.6% 88.4%
32 MeTu4b (R) ACh 20 10.0 0.6% 88.9%
33 LoVP38 (R) Glu 19 9.5 0.5% 89.5%
34 MeVC20 (R) Glu 19 9.5 0.5% 90.0%
35 MeVP41 (R) ACh 18 9.0 0.5% 90.5%
36 PLP211 (R) unclear 17 8.5 0.5% 90.9%
37 MeTu4f (R) ACh 16 8.0 0.4% 91.4%
38 Tm5c (R) Glu 15 7.5 0.4% 91.8%
39 aMe26 (R) ACh 11 5.5 0.3% 92.1%
40 MeLo6 (R) ACh 11 5.5 0.3% 92.4%
41 Pm8 (R) GABA 11 5.5 0.3% 92.7%
42 MeTu4c (R) ACh 10 5.0 0.3% 93.0%
43 MeVPMe9 (R) Glu 10 5.0 0.3% 93.3%
44 Mi17 (R) GABA 10 5.0 0.3% 93.5%
45 Tm35 (R) Glu 10 5.0 0.3% 93.8%
46 MeVP54 (R) unclear 9 4.5 0.2% 94.1%
47 Tm16 (R) ACh 8 4.0 0.2% 94.3%
48 aMe8 (R) ACh 7 3.5 0.2% 94.5%
49 Cm10 (R) GABA 6 3.0 0.2% 94.6%
50 Lat1 (R) unclear 6 3.0 0.2% 94.8%
51 LoVP12 (R) unclear 6 3.0 0.2% 95.0%
52 aMe9 (R) ACh 5 2.5 0.1% 95.1%
53 Cm16 (R) Glu 5 2.5 0.1% 95.2%
54 Cm6 (R) GABA 5 2.5 0.1% 95.4%
55 KCg-s1 (R) unclear 5 2.5 0.1% 95.5%
56 LoVP71 (R) ACh 5 2.5 0.1% 95.7%
57 MeVP6 (R) Glu 5 2.5 0.1% 95.8%
58 MeVPMe4 (R) Glu 5 2.5 0.1% 95.9%
59 aMe1 (R) GABA 4 2.0 0.1% 96.0%
60 aMe22 (R) Glu 4 2.0 0.1% 96.1%
61 MeVC21 (R) Glu 4 2.0 0.1% 96.3%
62 MeVP45 (R) ACh 4 2.0 0.1% 96.4%
63 MeVP49 (R) unclear 4 2.0 0.1% 96.5%
64 MeVPMe8 (R) Glu 4 2.0 0.1% 96.6%
65 AOTU045 (R) unclear 3 1.5 0.1% 96.7%
66 Cm17 (R) GABA 3 1.5 0.1% 96.8%
67 Cm23 (R) Glu 3 1.5 0.1% 96.8%
68 Dm2 (R) ACh 3 1.5 0.1% 96.9%
69 LoVP96 (R) Glu 3 1.5 0.1% 97.0%
70 MeVC9 (L) ACh 3 1.5 0.1% 97.1%
71 MeVC_unclear (R) Glu 3 1.5 0.1% 97.2%
72 MeVP33 (R) ACh 3 1.5 0.1% 97.2%
73 MeVPMe12 (R) ACh 3 1.5 0.1% 97.3%
74 MeVPMe3 (L) Glu 3 1.5 0.1% 97.4%
75 aMe17c (R) Glu 2 1.0 0.1% 97.5%
76 aMe4 (R) ACh 2 1.0 0.1% 97.5%
77 aMe5 (R) ACh 2 1.0 0.1% 97.6%
78 aMe6c (R) Glu 2 1.0 0.1% 97.6%
79 Cm11d (R) ACh 2 1.0 0.1% 97.7%
80 Cm21 (R) GABA 2 1.0 0.1% 97.7%
81 Cm28 (R) unclear 2 1.0 0.1% 97.8%
82 LC6 (R) ACh 2 1.0 0.1% 97.9%
83 Li39 (L) GABA 2 1.0 0.1% 97.9%
84 LoVP64 (R) unclear 2 1.0 0.1% 98.0%
85 LoVP83 (R) unclear 2 1.0 0.1% 98.0%
86 MeLo1 (R) ACh 2 1.0 0.1% 98.1%
87 MeTu4e (R) ACh 2 1.0 0.1% 98.1%
88 MeVPMe11 (L) Glu 2 1.0 0.1% 98.2%
89 MeVPMe4 (L) Glu 2 1.0 0.1% 98.2%
90 MeVPMe5 (R) Glu 2 1.0 0.1% 98.3%
91 Mi15 (R) ACh 2 1.0 0.1% 98.3%
92 PLP069 (R) unclear 2 1.0 0.1% 98.4%
93 PLP079 (R) unclear 2 1.0 0.1% 98.5%
94 Tm38 (R) ACh 2 1.0 0.1% 98.5%
95 Tm9 (R) ACh 2 1.0 0.1% 98.6%
96 TmY17 (R) ACh 2 1.0 0.1% 98.6%
97 TmY18 (R) ACh 2 1.0 0.1% 98.7%